Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course

INTRODUCTION: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is diagnosed by molecular-based detection of SARS-CoV-2 RNA. Serologic testing detects antibodies specific to SARS-CoV-2 and IgM specifically may serve as an adjunct test to PCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Higgins, Victoria, Fabros, Anselmo, Wang, Xiao Yan, Bhandari, Maria, Daghfal, David J., Kulasingam, Vathany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816645/
https://www.ncbi.nlm.nih.gov/pubmed/33476578
http://dx.doi.org/10.1016/j.clinbiochem.2021.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816645/
https://www.ncbi.nlm.nih.gov/pubmed/33476578
http://dx.doi.org/10.1016/j.clinbiochem.2021.01.003

Ejemplares similares